Table 3. Univariate and multivariate... | American Society of Hematology

Table 3.

Univariate and multivariate analysis of DFS and OS

	Disease-free survival			Overall survival
	Univariate analysis	Multivariate analysis		Univariate analysis	Multivariate analysis
	P value	P value^3-150	Pvalue^3-151	P value	P value^3-152	Pvalue^3-153
Achievement of CR (CR vs no CR)	—	—	—	<.0001	<.0001	<.0001
Age	.02	.03	.02	<.0001	NS	NS
Cytogenetics (good vs intermediate + poor)	.01	.04	.04	.005	NS	NS
WHO performance status (0-1 vs 2-4)	NS	—	—	.01	NS	NS
WBC count at diagnosis	NS	—	—	NS	—	—
LDH level	NS	—	—	NS	—	—
Pgp expression	.02	NS	NS	.0007	NS	NS
JC-1 (green fluorescence) + versus − (R vs I + S)	.02	.03	—	.0002	.0002	—
JC-1 (both green and red fluorescence) + versus − (R + I vs S)	.01	—	.01	.001	—	.02
Treatment (graft vs chemotherapy alone)	NS	—	—	.001	NS	NS

	Disease-free survival			Overall survival
	Univariate analysis	Multivariate analysis		Univariate analysis	Multivariate analysis
	P value	P value^3-150	Pvalue^3-151	P value	P value^3-152	Pvalue^3-153
Achievement of CR (CR vs no CR)	—	—	—	<.0001	<.0001	<.0001
Age	.02	.03	.02	<.0001	NS	NS
Cytogenetics (good vs intermediate + poor)	.01	.04	.04	.005	NS	NS
WHO performance status (0-1 vs 2-4)	NS	—	—	.01	NS	NS
WBC count at diagnosis	NS	—	—	NS	—	—
LDH level	NS	—	—	NS	—	—
Pgp expression	.02	NS	NS	.0007	NS	NS
JC-1 (green fluorescence) + versus − (R vs I + S)	.02	.03	—	.0002	.0002	—
JC-1 (both green and red fluorescence) + versus − (R + I vs S)	.01	—	.01	.001	—	.02
Treatment (graft vs chemotherapy alone)	NS	—	—	.001	NS	NS

NS indicates not significant.

F3-150

In this model, we have included age, cytogenetics, Pgp expression, and JC-1 (R vs I + S).

F3-151

In this model, we have included age, cytogenetics, Pgp expression, and JC-1 (R + I vs S).

F3-152

In this model, we have included achievement of CR, age, cytogenetics, WHO performance status, consolidation treatment, Pgp expression, and JC-1 (R vs I + S).

F3-153

In this model, we have included achievement of CR, age, cytogenetics, WHO performance status, consolidation treatment, Pgp expression, and JC-1 (R + I vs S).

View Large

This Feature Is Available To Subscribers Only